Skip to the page

Data / Form D filings / Galatea Bio, Inc.

Galatea Bio, Inc.: Form D filing

Galatea Bio, Inc., a health care company in Miami Lakes, FL, filed a Form D with the SEC in 2024. The latest, on September 6, 2024, reports $3.7 million sold of a $12 million offering to 4 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
14350 COMMERCE WAY, Miami Lakes, FL, 33016
Phone
(175) 423-3350
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2021
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2036550

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Sep 6, 2024New notice$12,000,000$3,656,000$8,344,0004Aug 23, 2024sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Nicholas D. KatsanisDirector
Carlos D. BustamanteExecutive Officer, Director
Muzammil D. MansuriDirector
Arthur D. PolkExecutive Officer
Wale D. AyeniDirector
Cindy D. CheungDirector
Alexander D. IoannidisDirector
Mohit D. KaushalDirector

Other health care companies in Florida that filed recently

Every Form D from the week of Sep 2, 2024 · All recent filings in Florida · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Galatea Bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.